Fenofibrate-loaded PLGA microparticles: Effects on ischemic stroke

European Journal of Pharmaceutical Sciences

Volumn 37, Issue 1, 2009, Pages 43-52

  Klose, D ^a,b   Laprais, M ^a   Leroux, V ^a   Siepmann, F ^a   Deprez, B ^a   Bordet, R ^a   Siepmann, J ^a  

^a UNIV LILLE   (France)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Brain; Controlled release; Local delivery; Microparticle; PLGA

Indexed keywords

FENOFIBRATE; FENOFIBRIC ACID; POLYGLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN INFARCTION SIZE; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG RELEASE; ENCAPSULATION; IN VIVO STUDY; METABOLITE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RAT; STRIATE CORTEX; WISTAR RAT;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL AVAILABILITY; CEREBRAL INFARCTION; DELAYED-ACTION PREPARATIONS; DRUG STABILITY; LACTIC ACID; MALE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; POROSITY; PROCETOFEN; RATS; RATS, WISTAR; STROKE; SURFACE PROPERTIES; TANDEM MASS SPECTROMETRY; X-RAY DIFFRACTION;

EID: 61349091651     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2008.12.016     Document Type: Article

References (42)

1. Abott N.J., and Romero I.A. Transporting therapeutics across the blood-brain barrier. Mol. Med. Today 2 (1996) 106-113
2. Anderson J.M., and Shive M.S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 28 (1997) 5-24
3. Aubert-Pouessel A., Bibby D.C., Venier-Julienne M.C., Hindré F., and Benoit J.P. A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres. Pharm. Res. 19 (2002) 1046-1051
4. Beduneau A., Saulnier P., and Benoit J.P. Active targeting of brain tumors using nanocarriers. Biomaterials 28 (2007) 4947-4967
5. Benoit J.P., Faisant N., Venier-Julienne M.C., and Menei P. Development of microspheres for neurological disorders: from basics to clinical applications. J. Control. Release 65 (2000) 285-296
6. Berkland C., Pollauf E., Raman C., Silverman R., Kim K., and Pack D.W. Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism. J. Pharm. Sci. 96 (2007) 1176-1191
7. Blasi P., Giovagnoli S., Schoubben A., Ricci M., Rossi C., Luca G., Basta G., and Calafiore R. Preparation and in vitro and in vivo characterization of composite microcapsules for cell encapsulation. Int. J. Pharm. 324 (2006) 27-36
8. Blasi P., Schoubben A., Giovagnoli S., Perioli L., Ricci M., and Rossi C. Ketoprofen poly(lactide-co-glycolide) physical interaction. AAPS PharmSciTech. 8 2 (2007) 37 article
9. Bordet R., Ouk T., Petrault O., Gele P., Gautier S., Laprais M., Deplanque D., Duriez P., Staels B., Fruchart J.C., and Bastide M. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem. Soc. Trans. 34 (2006) 1341-1346
10. Bosca F., and Miranda M.A. New Trends in Photobiology: photosensitizing drugs containing the benzophenone chromophore. J. Photochem. Photobiol. B 43 (1998) 1-26
11. Brem H., Walter K., and Langer R. Polymers as controlled drug delivery devices for the treatment of malignant brain tumors. Eur. J. Pharm. Biopharm. 27 (1993) 2-7
12. Brem H., Ewend M.G., Piantadosi S., Greenhoot J., Burger P.C., and Sisti M. The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial. J. Neurooncol. 26 (1995) 111-123
13. Brem H., and Gabikian O. Biodegradable polymer implants to treat brain tumors. J. Control. Release 74 (2001) 63-67
14. Brunner A., Maeder K., and Goepferich A. pH and osmotic pressure inside biodegradable microspheres during erosion. Pharm. Res. 16 (1999) 847-853
15. Deplanque D., Gele P., Petrault O., Six I., Furman C., Bouly M., Nion S., Dupuis B., Leys D., and Fruchart J.C. Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J. Neurosci. 23 (2003) 6264-6271
16. Faisant N., Siepmann J., and Benoit J.P. PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release. Eur. J. Pharm. Sci. 15 (2002) 355-366
17. Fournier E., Passirani C., Montero-Menei C.N., and Benoit J.P. Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility. Biomaterials 24 (2003) 3311-3331
18. Freiberg S., and Zhu X.X. Polymer microspheres for controlled drug release. Int. J. Pharm. 282 (2004) 1-18
19. Grieg N.H. Optimizing drug delivery to brain tumors. Cancer Treat. Rev. 14 (1987) 1-28
20. Hanafy A., Spahn-Langguth H., Vergnault G., Grenier P., Tubic Grozdanis M., Lenhardt T., and Langguth P. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Adv. Drug Del. Rev. 59 (2007) 419-426
21. Heneka M.T., and Landreth G.E. PPARs in the brain. Biochim. Biophys. Acta 1771 (2007) 1031-1045
22. Klose D., Siepmann F., Elkharraz K., Krenzlin S., and Siepmann J. How porosity and size affect the drug release mechanisms from PLGA-based microparticles. Int. J. Pharm. 314 (2006) 198-206
23. Li L., and Schwendeman S.P. Mapping neutral microclimate pH in PLGA microspheres. J. Control. Release 101 (2005) 163-173
24. Mackay J., and Mensah G. Atlas of Heart Disease and Stroke (2004), WHO Press, Geneva
25. Menei P., Jadaud E., Faisant N., Boisdron-Celle M., Michalak S., Fournier D., Delhaye M., and Benoit J.P. Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma. Cancer 100 (2004) 405-410
26. Menei P., Montero-Menei C., Venier M.C., and Benoit J.P. Drug delivery into the brain using poly(lactide-co-glycolide) microspheres. Expert Opin. Drug Deliv. 2 (2005) 363-376
27. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, London
28. Reinhard C.S., Radomsky M.L., Saltzman W., Hilton M., and Brem J.H. Polymeric controlled release of dexamethasone in normal rat brain. J. Control. Release 16 (1991) 331-339
29. Rival Y., Beneteau N., Taillandier T., Pezet M., Dupont-Passelaigue E., Patoiseau J.F., Junquero D., Colpaert F.C., and Delhon A. PPARa and PPARd activators inhibit cytokine-induced nuclear translocation of NF-kB and expression of VCAM-1 in EAhy926 endothelial cells. Eur. J. Pharmacol. 435 (2002) 143-151
30. Sacco R.L., Chong J.Y., Prabhakaran S., and Elkind M.S.V. Experimental treatments for acute ischaemic stroke. Lancet 369 (2007) 331-341
31. Saltzman W.M., Mak M.W., Mahoney M.J., Duenas E.T., and Cleland J.L. Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems. Pharm. Res. 16 (1999) 232-240
32. Siepmann J., Faisant N., and Benoit J.P. A new mathematical model quantifying drug release from bioerodible microparticles using Monte Carlo simulations. Pharm. Res. 19 (2002) 1885-1893
33. Siepmann J., Elkharraz K., Siepmann F., and Klose D. How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment. Biomacromolecules 6 (2005) 2312-2319
34. Siepmann J., Siepmann F., and Florence A.T. Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms. Int. J. Pharm. 314 (2006) 101-119
35. Streel B., Hubert P., and Ceccato A. Determination of fenofibric acid in human plasma using automated solid-phase extraction coupled to liquid chromatography. J. Chromatogr. B 742 (2000) 391-400
36. Valtonen S., Timonen U., Toivanen P., Kalimo H., Kivipelto L., Heiskanen O., Unsgaard G., and Kuurne T. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 41 (1997) 44-49
37. Visscher G.E., Robison R.L., Maulding H.V., Fong J.W., Pearson J.E., and Argentieri G.J. Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules. J. Biomed. Mater. Res. 19 (1985) 349-365
38. Vogt M., Kunath K., and Dressman J.B. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations. Eur. J. Pharm. Sci. 68 (2008) 283-288
39. Wang P.P., Frazier J., and Brem H. Local drug delivery to the brain. Adv. Drug Deliv. Rev. 54 (2002) 987-1013
40. Weil A., Caldwell J., and Strolin-Benedetti M. The metabolism and disposition of fenofibrate in rat, guinea pig, and dog. Drug Metab. Dispos. 16 (1988) 302-309
41. Woo B.H., Kostanski J.W., Gebrekidan S., Dani B.A., Thanoo B.C., and DeLuca P.P. Preparation, characterization and in vivo evaluation of 120-day poly(d,l-lactide) leuprolide microspheres. J. Control. Release 75 (2001) 307-315
42. Young A.R., Ali C., Duretete A., and Vivien D. Neuroprotection and stroke: time for a compromise. J. Neurochem. 103 (2007) 1302-1309